Nanoparticle Technologies

Nanoparticle Technologies, Inc. (NTI) is a biotechnology company specializing in the design, development, and manufacture of high-quality gold nanoparticles and nanoparticle conjugates. Based in Alachua, Florida, the company provides specialized services for the diagnostic and research markets, particularly in the development of lateral flow assays and biosensors. NTI's expertise lies in precise particle size control and stable protein-nanoparticle conjugation, which are critical for the sensitivity and reproducibility of rapid diagnostic tests. In 2014, the company was acquired by BBI Solutions to expand its global footprint and enhance its portfolio of gold reagents and conjugation services.